These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, Vicennati V, Carcello A, Labate AM. Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643 [Abstract] [Full Text] [Related]
5. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids. Duclos M, Gatta B, Corcuff JB, Rashedi M, Pehourcq F, Roger P. Clin Endocrinol (Oxf); 2001 Oct; 55(4):447-54. PubMed ID: 11678826 [Abstract] [Full Text] [Related]
6. alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity. Pasquali R, Vicennati V, Calzoni F, Gnudi U, Gambineri A, Ceroni L, Cortelli P, Menozzi R, Sinisi R, Rio GD. Clin Endocrinol (Oxf); 2000 Apr; 52(4):413-21. PubMed ID: 10762283 [Abstract] [Full Text] [Related]
7. Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment. Kok P, Kok SW, Buijs MM, Westenberg JJ, Roelfsema F, Frölich M, Stokkel MP, Meinders AE, Pijl H. Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E848-56. PubMed ID: 15280154 [Abstract] [Full Text] [Related]
8. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. Pasquali R, Ambrosi B, Armanini D, Cavagnini F, Uberti ED, Del Rio G, de Pergola G, Maccario M, Mantero F, Marugo M, Rotella CM, Vettor R, Study Group on Obesity of the Italian Society of Endocrinology. J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642 [Abstract] [Full Text] [Related]
9. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. Vicennati V, Pasquali R. J Clin Endocrinol Metab; 2000 Nov; 85(11):4093-8. PubMed ID: 11095438 [Abstract] [Full Text] [Related]
11. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome. Pasquali R, Gagliardi L, Vicennati V, Gambineri A, Colitta D, Ceroni L, Casimirri F. Int J Obes Relat Metab Disord; 1999 Apr; 23(4):419-24. PubMed ID: 10340821 [Abstract] [Full Text] [Related]
13. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity. Tsagarakis S, Vasiliou V, Kokkoris P, Stavropoulos G, Thalassinos N. Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315 [Abstract] [Full Text] [Related]
16. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women. Loucks AB, Mortola JF, Girton L, Yen SS. J Clin Endocrinol Metab; 1989 Feb; 68(2):402-11. PubMed ID: 2537332 [Abstract] [Full Text] [Related]
17. Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. Korbonits M, Trainer PJ, Nelson ML, Howse I, Kopelman PG, Besser GM, Grossman AB, Svec F. Clin Endocrinol (Oxf); 1996 Dec; 45(6):699-706. PubMed ID: 9039335 [Abstract] [Full Text] [Related]
19. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol]. Robaczyk MG. Ann Acad Med Stetin; 2002 Dec; 48():283-300. PubMed ID: 14601484 [Abstract] [Full Text] [Related]
20. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R. J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]